Article Details

Ide-Cel Earns European Approval in Triple-Class Exposed Multiple Myeloma

Retrieved on: 2024-03-21 21:01:54

Tags for this article:

Click the tags to see associated articles and topics

Ide-Cel Earns European Approval in Triple-Class Exposed Multiple Myeloma. View article details on hiswai:

Excerpt

The European Commission has granted approval to idecabtagene vicleucel (ide-cel; Abecma) as a treatment for adult patients with ...

Article found on: www.cancernetwork.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo